U.S. markets open in 8 hours 27 minutes
  • S&P Futures

    4,569.75
    +11.75 (+0.26%)
     
  • Dow Futures

    35,663.00
    +43.00 (+0.12%)
     
  • Nasdaq Futures

    15,573.75
    +78.00 (+0.50%)
     
  • Russell 2000 Futures

    2,315.70
    +5.40 (+0.23%)
     
  • Crude Oil

    83.89
    +0.13 (+0.16%)
     
  • Gold

    1,804.40
    -2.40 (-0.13%)
     
  • Silver

    24.48
    -0.11 (-0.46%)
     
  • EUR/USD

    1.1606
    -0.0008 (-0.07%)
     
  • 10-Yr Bond

    1.6350
    0.0000 (0.00%)
     
  • Vix

    15.24
    -0.19 (-1.23%)
     
  • GBP/USD

    1.3762
    -0.0006 (-0.05%)
     
  • USD/JPY

    113.9390
    +0.2400 (+0.21%)
     
  • BTC-USD

    62,520.51
    +461.45 (+0.74%)
     
  • CMC Crypto 200

    1,502.68
    +1,260.00 (+519.20%)
     
  • FTSE 100

    7,222.82
    +18.27 (+0.25%)
     
  • Nikkei 225

    29,123.30
    +522.89 (+1.83%)
     

1 Beaten-Down Stock With 10X Potential

·4 min read
1 Beaten-Down Stock With 10X Potential
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

The biotech industry is an excellent place to start. Clinical trial victories and regulatory approvals can send shares of a biotech soaring, especially one with a relatively small stock market capitalization. Let's look closer at one biotech whose shares have been hammered over the past few months, Axsome Therapeutics (NASDAQ: AXSM), and consider why this company still has some serious potential.